{
  "docId": "019de073-a711-71bb-a4fc-67d28d18b8d8",
  "docSlug": "26ea3d305f04fe3e604b448e70b259ea",
  "documentTitle": "BenevolentAI | Investor Presentation Deck | 46 slides",
  "authorId": "benevolentai",
  "authorName": "BenevolentAI",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 15,
  "pageCount": 46,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a list-based framework to demonstrate the 'Novel, Rapid, Effective' nature of their AI-driven discovery process.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-a711-71bb-a4fc-67d28d18b8d8/15",
  "deckHref": "/decks/019de073-a711-71bb-a4fc-67d28d18b8d8",
  "deckJsonHref": "/decks/019de073-a711-71bb-a4fc-67d28d18b8d8.json",
  "deckAnchorHref": "/decks/019de073-a711-71bb-a4fc-67d28d18b8d8#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.7,
        "y": 0.7
      },
      "kind": "image",
      "text": "Eli Lilly",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d7fa35d-66d7-4440-9cdf-39fe9fdb9ff9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.7,
        "y": 0.4
      },
      "kind": "image",
      "text": "The Lancet",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4269d253-20d3-4453-8b67-b4d1592405aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.6,
        "x": 0.05,
        "y": 0.275
      },
      "kind": "list",
      "text": "NOVEL: Our technology and AI workflows identified a previously unknown antiviral mechanism. RAPID: The Benevolent Platform empowered scientists to rapidly formulate a hypothesis in just 48 hours. EFFECTIVE: Baricitinib shown to reduce mortality by 38% in hospitalised patients, and by 46% in ventilated or ECMO patients. FDA approved the use of baricitinib to treat COVID-19 in May 2022.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ad14795-5682-47b6-a9d3-e4818bdd0a61",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.93
      },
      "kind": "source-note",
      "text": "Sources: (1) Richardson et al. Lancet 2020; (2) Marconi et al. Lancet Respiratory Medicine 2021; (3) Ely et al. Lancet Respiratory Medicine 2022; (4) Lilly press release 11 May 2022; (5) Lilly press release 19 Nov 2020",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a4f771cd-ba0c-4895-afbc-dff2af32ed46",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "Regulatory validation: identified a COVID-19 treatment now fully approved for use by the FDA",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "82494edf-5430-40af-a00d-81ea3e74c113",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "b70ce831-0bcb-4227-a466-ee8a8debceee",
      "evidence": "The slide uses a structured list to present the value proposition and validation points.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}